Literature DB >> 25937537

Transcriptional and proteomic analyses of two-component response regulators in multidrug-resistant Mycobacterium tuberculosis.

Lei Zhou1, Liu Yang1, Xianfei Zeng1, Jiacuo Danzheng1, Qing Zheng1, Jiayun Liu1, Feng Liu2, Yijuan Xin1, Xiaodong Cheng1, Mingquan Su1, Yueyun Ma3, Xiaoke Hao4.   

Abstract

Two-component systems (TCSs) have been reported to exhibit a sensing and responding role under drug stress that induces drug resistance in several bacterial species. However, the relationship between TCSs and multidrug resistance in Mycobacterium tuberculosis has not been comprehensively analysed to date. In this study, 90 M. tuberculosis clinical isolates were analysed using 15-loci mycobacterial interspersed repetitive unit (MIRU)-variable number tandem repeat (VNTR) typing and repetitive extragenic palindromic (rep)-PCR-based DNA fingerprinting. The results showed that all of the isolates were of the Beijing lineage, and strains with a drug-susceptible phenotype had not diverged into similar genotype clusters. Expression analysis of 13 response regulators of TCSs using real-time PCR and tandem mass spectrometry (MS/MS) proteomic analysis demonstrated that four response regulator genes (devR, mtrA, regX3 and Rv3143) were significantly upregulated in multidrug-resistant (MDR) strains compared with the laboratory strain H37Rv as well as drug-susceptible and isoniazid-monoresistant strains (P<0.05). DNA sequencing revealed that the promoter regions of devR, mtrA, regX3 and Rv3143 did not contain any mutations. Moreover, expression of the four genes could be induced by most of the four first-line antitubercular agents. In addition, either deletion or overexpression of devR in Mycobacterium bovis BCG did not alter its sensitivity to the four antitubercular drugs. This suggests that upregulation of devR, which is common in MDR-TB strains, might be induced by drug stress and hypoxic adaptation following the acquisition of multidrug resistance.
Copyright © 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Keywords:  Multiple drug resistance; Mycobacterium tuberculosis; Two-component system; devR; mtrA; regX3

Mesh:

Substances:

Year:  2015        PMID: 25937537     DOI: 10.1016/j.ijantimicag.2015.02.018

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  5 in total

1.  The Orphan Response Regulator Rv3143 Modulates the Activity of the NADH Dehydrogenase Complex (Nuo) in Mycobacterium tuberculosis via Protein-Protein Interactions.

Authors:  Renata Płocińska; Karolina Wasik; Przemysław Płociński; Ewelina Lechowicz; Magdalena Antczak; Ewelina Błaszczyk; Bożena Dziadek; Marcin Słomka; Anna Rumijowska-Galewicz; Jarosław Dziadek
Journal:  Front Cell Infect Microbiol       Date:  2022-06-28       Impact factor: 6.073

2.  A temporal proteome dynamics study reveals the molecular basis of induced phenotypic resistance in Mycobacterium smegmatis at sub-lethal rifampicin concentrations.

Authors:  Alexander D Giddey; Elise de Kock; Kehilwe C Nakedi; Shaun Garnett; Andrew J M Nel; Nelson C Soares; Jonathan M Blackburn
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

3.  Genomic and transcriptomic analysis of the streptomycin-dependent Mycobacterium tuberculosis strain 18b.

Authors:  Andrej Benjak; Swapna Uplekar; Ming Zhang; Jérémie Piton; Stewart T Cole; Claudia Sala
Journal:  BMC Genomics       Date:  2016-03-05       Impact factor: 3.969

4.  High rate of drug resistance among tuberculous meningitis cases in Shaanxi province, China.

Authors:  Ting Wang; Guo-Dong Feng; Yu Pang; Jia-Yun Liu; Yang Zhou; Yi-Ning Yang; Wen Dai; Lin Zhang; Qiao Li; Yu Gao; Ping Chen; Li-Ping Zhan; Ben J Marais; Yan-Lin Zhao; Gang Zhao
Journal:  Sci Rep       Date:  2016-05-04       Impact factor: 4.379

5.  Differential roles of the hemerythrin-like proteins of Mycobacterium smegmatis in hydrogen peroxide and erythromycin susceptibility.

Authors:  Xiaojing Li; Jingjing Li; Xinling Hu; Lige Huang; Jing Xiao; John Chan; Kaixia Mi
Journal:  Sci Rep       Date:  2015-11-26       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.